These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15332589)

  • 1. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitors and endothelial dysfunction.
    Carretaro OA
    Am J Hypertens; 1995 May; 8(5 Pt 2):42S-44S. PubMed ID: 7646843
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction and the promise of ACE inhibitors.
    Rockett JL
    Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular diseases. Improvement of the endothelial function as strategic therapeutic aim].
    Z Kardiol; 1998 Jun; 87(6 Suppl Besserung):1-4. PubMed ID: 9698652
    [No Abstract]   [Full Text] [Related]  

  • 7. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 8. ACE inhibitors, diabetes and cardiovascular disease.
    Gazis A; Page SR; Cockcroft JR
    Diabetologia; 1998 May; 41(5):595-7. PubMed ID: 9628279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis].
    Egido J; Ruiz-Ortega M; Muñoz-García B; Martín-Ventura JL; Blanco-Colio LM
    Nefrologia; 2005; 25 Suppl 2():117-28. PubMed ID: 16050414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing endothelial dysfunction with ACE inhibitors. A new trend.
    Rajagopalan S; Harrison DG
    Circulation; 1996 Aug; 94(3):240-3. PubMed ID: 8759059
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel therapies targeting vascular endothelium.
    Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
    Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of angiotensin converting enzyme inhibitors.
    Chatterjee K
    Heart Dis Stroke; 1992; 1(3):128-33. PubMed ID: 1344097
    [No Abstract]   [Full Text] [Related]  

  • 13. What is the role of angiotensin-receptor blockade in cardiovascular protection?
    Cohn JN
    Am Heart J; 2006 Nov; 152(5):859.e1-8. PubMed ID: 17070145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.
    Galderisi M; de Divitiis O
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system.
    Diz DI
    Mol Interv; 2008 Oct; 8(5):222-5. PubMed ID: 19015385
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV; Deedwania PC
    Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular rho kinases and their potential therapeutic applications.
    Budzyn K; Sobey CG
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):590-6. PubMed ID: 17786858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chinese expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular diseases].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):97-106. PubMed ID: 17445398
    [No Abstract]   [Full Text] [Related]  

  • 20. [ACE-inhibitors: the indication spectrum grows wider].
    Fortschr Med Suppl; 1996; 178():1-10. PubMed ID: 9022411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.